LUCD
Price
$0.38Alerts
Change
-$0.02 (-5.00%)
Updated
Nov 11 closing price
Capitalization
76M
Earnings call today
Intraday BUY SELL Signals
NXL
Price
$1.59Alerts
Change
+$0.12 (+8.16%)
Updated
Nov 11 closing price
Capitalization
1.22M
One day until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

LUCD vs NXL

LUCD vs NXL Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
LUCD vs. NXL commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LUCD is a Hold and NXL is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for LUCD with price predictions
Nov 11, 2026

LUCD's RSI Indicator ascending out of oversold territory

The RSI Oscillator for LUCD moved out of oversold territory on October 23, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 37 similar instances when the indicator left oversold territory. In 34 of the 37 cases the stock moved higher. This puts the odds of a move higher at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Moving Average Convergence Divergence (MACD) for LUCD just turned positive on October 27, 2026. Looking at past instances where LUCD's MACD turned positive, the stock continued to rise in 40 of 47 cases over the following month. The odds of a continued upward trend are 85%.

Following a +7.02% 3-day Advance, the price is estimated to grow further. Considering data from situations where LUCD advanced for three days, in 199 of 247 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

LUCD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on LUCD as a result. In 79 of 94 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 84%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LUCD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.

The Aroon Indicator for LUCD entered a downward trend on November 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 55 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.955) is normal, around the industry mean (4.142). P/E Ratio (-0.971) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (21.645) is also within normal values, averaging (40.124).

The Tickeron Price Growth Rating for this company is 92 (best 1 - 100 worst), indicating slightly worse than average price growth. LUCD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LUCD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for NXL with price predictions
Nov 11, 2026

NXL sees its Stochastic Oscillator climbs out of oversold territory

On November 10, 2026, the Stochastic Oscillator for NXL moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 52 instances where the indicator left the oversold zone. In 42 of the 52 cases the stock moved higher in the following days. This puts the odds of a move higher at over 81%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a +7.14% 3-day Advance, the price is estimated to grow further. Considering data from situations where NXL advanced for three days, in 142 of 179 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.

Bearish Trend Analysis

The 50-day moving average for NXL moved below the 200-day moving average on November 05, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NXL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for NXL entered a downward trend on November 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 49 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.802) is normal, around the industry mean (4.142). P/E Ratio (-0.107) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (14.620) is also within normal values, averaging (40.124).

The Tickeron Price Growth Rating for this company is 97 (best 1 - 100 worst), indicating slightly worse than average price growth. NXL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NXL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

TECHNICAL ANALYSIS
Technical Analysis
LUCDNXL
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
Bearish Trend 1 day ago
84%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
85%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
79%
Declines
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
88%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (LUCD: $0.40 vs. NXL: $1.47)
Brand notoriety: LUCD and NXL are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: LUCD: 31% vs. NXL: 2%
Market capitalization -- LUCD: $76M vs. NXL: $1.22M
LUCD [@Medical/Nursing Services] is valued at $76M. NXL’s [@Medical/Nursing Services] market capitalization is $1.22M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $190.22B. The average market capitalization across the [@Medical/Nursing Services] industry is $6.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LUCD’s FA Score shows that 1 FA rating(s) are green while NXL’s FA Score has 0 green FA rating(s).

  • LUCD’s FA Score: 1 green, 4 red.
  • NXL’s FA Score: 0 green, 5 red.
According to our system of comparison, LUCD is a better buy in the long-term than NXL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LUCD’s TA Score shows that 5 TA indicator(s) are bullish while NXL’s TA Score has 2 bullish TA indicator(s).

  • LUCD’s TA Score: 5 bullish, 3 bearish.
  • NXL’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, LUCD is a better buy in the short-term than NXL.

Price Growth

LUCD (@Medical/Nursing Services) experienced а -2.20% price change this week, while NXL (@Medical/Nursing Services) price change was -4.55% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.89%. For the same industry, the average monthly price growth was -4.69%, and the average quarterly price growth was -1.76%.

Reported Earning Dates

LUCD is expected to report earnings on Nov 12, 2026.

NXL is expected to report earnings on Nov 13, 2026.

Industries' Descriptions

@Medical/Nursing Services (-2.89% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

LUCD and

Correlation & Price change

A.I.dvisor tells us that LUCD and FEMY have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LUCD and FEMY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LUCD
1D Price
Change %
LUCD100%
-4.65%
FEMY - LUCD
30%
Poorly correlated
+4.90%
CNMD - LUCD
27%
Poorly correlated
-0.86%
CRL - LUCD
27%
Poorly correlated
-0.90%
BBNX - LUCD
26%
Poorly correlated
+7.81%
ELMD - LUCD
26%
Poorly correlated
-8.17%
More

NXL and

Correlation & Price change

A.I.dvisor indicates that over the last year, NXL has been loosely correlated with PFSA. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if NXL jumps, then PFSA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NXL
1D Price
Change %
NXL100%
+8.16%
PFSA - NXL
33%
Loosely correlated
+0.18%
QSI - NXL
28%
Poorly correlated
-0.78%
HYPR - NXL
27%
Poorly correlated
+4.42%
LUCD - NXL
27%
Poorly correlated
-4.65%
ITGR - NXL
24%
Poorly correlated
+0.05%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FMAY57.280.49
+0.86%
FT Vest U.S. Equity Buffer Fund - May (FMAY)
MANI26.000.04
+0.14%
Man Active Income ETF (MANI)
EMHC24.140.02
+0.06%
State Street SPDR Bloomberg Emerging Markets USD Bond ETF (EMHC)
MILN45.74N/A
N/A
Global X Millennial Consumer ETF (MILN)
QQMY24.95N/A
N/A
Corgi Growth & Technology 15% Structured Buffer ETF (QQMY)